Literature DB >> 17181838

Late results of gelatin-resorcin-formalin glue-aided repair in acute type A aortic dissection.

Motomi Shiono1, Mitsumasa Hata, Akira Sezai, Tetsuya Niino, Shinya Yagi, Nanao Negishi.   

Abstract

Gelatin-resorcin-formalin (GRF) glue has been used to obliterate the false lumen of dissected aortas, resulting in reduced mortality. However, because of the cytotoxicity of formalin, the application of GRF remains controversial. In this study, a total of 138 consecutive patients with acute type A dissection since 1995, who underwent emergency graft replacement, were reviewed. The mean age was 65.5 years. The hospital mortality rate was 6.5%. In-hospital re-exploration rate and patency rate of the false lumen were 6.5% and 24.7%, respectively. The actuarial survival rates were 81.5% after 5 years and 54.8% after 10 years. Reoperation-free rates were 87.9% after 5 years and 72.3% after 10 years. Tissue necrosis or aneurismal degeneration was not demonstrated at reoperation. In conclusion, GRF glue demonstrats excellent tissue adhesion and hemostasis capability, and contributes to improve surgical results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17181838     DOI: 10.1111/j.1525-1594.2006.00328.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Recent status of gelatin-resorcin-formalin glue for acute type A aortic dissection.

Authors:  Kiyotaka Imoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

2.  A case of ascending aortic pseudoaneurysm in a patient with aortic replacement.

Authors:  Yuichi Ishida; Yasuhito Sakano; Shin-ichi Ohki; Arata Muraoka; Kei Aizawa; Yoshio Misawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-04-28

Review 3.  Surgery for acute aortic dissection using gelatin-resorcin-formalin glue: perspective from 10 years of follow-up at a single center.

Authors:  Motomi Shiono
Journal:  J Artif Organs       Date:  2008-04-15       Impact factor: 1.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.